logo

For the Inventor, By the Inventor

St. Hyacinthe, Canada

Simon H Drouin

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Tremeau Pharmaceuticals, Inc.. Active years: 2021-2024.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal5 out of 8 
 
Tremeau Pharmaceuticals, Inc.
 patents

Years Active: 2021-2024

Loading Chart...
5 patents (USPTO):Explore Patents
1. 11872206 - Purified forms of rofecoxib, methods of manufacture and use (2024-01-16),
2. 11617735 - Purified forms of rofecoxib, methods of manufacture and use (2023-04-04),
3. 11576890 - Purified forms of rofecoxib, methods of manufacture and use (2023-02-14),
4. 11559509 - Purified forms of rofecoxib, methods of manufacture and use (2023-01-24),
5. 10987337 - Purified forms of rofecoxib, methods of manufacture and use (2021-04-27),

Title: Simon H Drouin - Inventor from Saint-Hyacinthe, CA

Introduction: Simon H Drouin is a renowned inventor hailing from Saint-Hyacinthe, Canada, known for his groundbreaking innovations in various fields.

Latest Patents: Simon H Drouin holds several patents in the areas of renewable energy technologies, agricultural machinery, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Simon H Drouin has worked with leading research institutions and universities to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Simon H Drouin has collaborated with top companies, inventors, and patent attorneys to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Simon H Drouin's passion for innovation and his relentless pursuit of excellence have solidified his position as a pioneering inventor in the Canadian innovation landscape.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…